Correction: Urine protein:creatinine ratio vs 24-hour urine protein for proteinuria management: analysis from the phase 3 REFLECT study of lenvatinib vs sorafenib in hepatocellular carcinoma

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Correction to: British Journal of Cancer; 10.1038/s41416-019-0506-6; published online 28 June 2019. This article was originally published under a standard license to Publish, but has now been made available under a CC BY license. The PDF and HTML versions of the paper have been modified accordingly.

Related collections

Author and article information

Contributors

Thomas R. Jeffry Evans: j.evans@beatson.gla.ac.uk

Journal

Journal ID (nlm-ta): Br J Cancer

Journal ID (iso-abbrev): Br. J. Cancer

Title: British Journal of Cancer

Publisher: Nature Publishing Group UK (London )

ISSN (Print): 0007-0920

ISSN (Electronic): 1532-1827

Publication date (Electronic): 30 July 2019

Publication date PMC-release: 30 July 2019

Publication date (Print): 1 October 2019

Volume: 121

Issue: 7

Page: 625

Affiliations

[1 ]ISNI 0000 0001 2193 314X, GRID grid.8756.c, University of Glasgow, Beatson West of Scotland Cancer Centre, ; Glasgow, UK

[2 ]ISNI 0000 0004 1936 9967, GRID grid.258622.9, Department of Gastroenterology and Hepatology, , Kindai University Faculty of Medicine, ; Osaka, Japan

[3 ]ISNI 0000 0000 9142 8600, GRID grid.413083.d, David Geffen School of Medicine, , UCLA Medical Center, ; Los Angeles, CA USA

[4 ]ISNI 0000 0004 0470 5454, GRID grid.15444.30, Severance Hospital, , Yonsei University, ; Seoul, South Korea

[5 ]ISNI 0000 0004 0572 7815, GRID grid.412094.a, National Taiwan University Hospital and National Taiwan University Cancer Center, ; Taipei, Taiwan

[6 ]ISNI 0000 0001 2168 5385, GRID grid.272242.3, Department of Hepatobiliary and Pancreatic Oncology, , National Cancer Center Hospital East, ; Kashiwa, Japan

[7 ]GRID grid.428696.7, Former employee of Eisai Ltd, ; Hatfield, UK

[8 ]ISNI 0000 0004 0599 8842, GRID grid.418767.b, Eisai Inc., ; Woodcliff Lake, NJ USA

[9 ]Unit of Internal Medicine, University of Bologna, S.Orsola-Malpighi Hospital, Bologna, Italy

[10 ]GRID grid.416167.3, Tisch Cancer Institute at Mount Sinai, ; New York, NY USA

Article

Publisher ID: 534

DOI: 10.1038/s41416-019-0534-2

PMC ID: 6889263

PubMed ID: 31363170

SO-VID: dc0f5197-5987-4e19-8bd8-d864ad51d6b3

License:

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

History

Custom metadata

ScienceOpen disciplines: Oncology & Radiotherapy

Keywords: cancer

Data availability:

ScienceOpen disciplines: Oncology & Radiotherapy

Keywords: cancer

Comments

Comment on this article

scite_

Cited by 2

See all cited by

- Version 1